| 000 | 01498 a2200409 4500 | ||
|---|---|---|---|
| 005 | 20250513184151.0 | ||
| 264 | 0 | _c19990907 | |
| 008 | 199909s 0 0 eng d | ||
| 022 | _a0302-2838 | ||
| 024 | 7 |
_a10.1159/000019919 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aDjavan, B | |
| 245 | 0 | 0 |
_aA meta-analysis on the efficacy and tolerability of alpha1-adrenoceptor antagonists in patients with lower urinary tract symptoms suggestive of benign prostatic obstruction. _h[electronic resource] |
| 260 |
_bEuropean urology _c1999 |
||
| 300 |
_a1-13 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Meta-Analysis | ||
| 650 | 0 | 4 |
_aAdrenergic alpha-Antagonists _xadverse effects |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aAged, 80 and over |
| 650 | 0 | 4 | _aControlled Clinical Trials as Topic |
| 650 | 0 | 4 |
_aDizziness _xchemically induced |
| 650 | 0 | 4 | _aDose-Response Relationship, Drug |
| 650 | 0 | 4 |
_aDoxazosin _xadverse effects |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aHypotension, Orthostatic _xchemically induced |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aPrazosin _xadverse effects |
| 650 | 0 | 4 | _aPrognosis |
| 650 | 0 | 4 |
_aProstatic Hyperplasia _xcomplications |
| 650 | 0 | 4 |
_aQuinazolines _xadverse effects |
| 650 | 0 | 4 | _aTreatment Outcome |
| 650 | 0 | 4 |
_aUrologic Diseases _xdiagnosis |
| 700 | 1 | _aMarberger, M | |
| 773 | 0 |
_tEuropean urology _gvol. 36 _gno. 1 _gp. 1-13 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1159/000019919 _zAvailable from publisher's website |
| 999 |
_c10323186 _d10323186 |
||